GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » 3-Year FCF Growth Rate

Siemens Healthineers AG (WBO:SHL) 3-Year FCF Growth Rate : -2.50% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG 3-Year FCF Growth Rate?

Siemens Healthineers AG's Free Cash Flow per Share for the three months ended in Sep. 2024 was €1.10.

During the past 12 months, Siemens Healthineers AG's average Free Cash Flow per Share Growth Rate was 66.30% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -2.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 6.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 10 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Siemens Healthineers AG was 24.30% per year. The lowest was -11.70% per year. And the median was -3.30% per year.


Competitive Comparison of Siemens Healthineers AG's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Siemens Healthineers AG's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siemens Healthineers AG's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's 3-Year FCF Growth Rate falls into.



Siemens Healthineers AG 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Siemens Healthineers AG  (WBO:SHL) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Siemens Healthineers AG 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Siemens Healthineers AG Business Description

Address
Siemensstr. 3, Forchheim, BY, DEU, 91301
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines